Summary of the National Advisory Committee on Immunization (NACI) Rapid Response: Updated interim guidance on Imvamune in the context of ongoing monkeypox outbreaks

CONCLUSION: The updated NACI recommendations provide additional guidance on the use of Imvamune for the management of the 2022 monkeypox outbreak in Canada and may be considered to maximize vaccine coverage in outbreak settings when supply is limited.PMID:38192609 | PMC:PMC10773661 | DOI:10.14745/ccdr.v48i1112a11
Source: Can Commun Dis Rep - Category: Infectious Diseases Authors: Source Type: research